David Einhorn, who publicly shorted Lehman Brothers stock in the summer of 2008, fought a very public battle against Allied Capital and won big at the 2006 World Series of Poker is putting up some of his chips on Boston Scientific Corp (NYSE:BSX).
Einhorn, the president of New York-based Greenlight Capital, recently disclosed a more than $300 million stake in the Natick, Mass.-based medical device company, according to filings with the U.S. Securities and Exchange Commission.
Einhorn bought some 32 million shares in October at an average price of $8.42 oer share, according to a letter sent out to shareholders of Greenlight in mid-January.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
“We believe that BSX’s well incentivized and seemingly very capable new CEO will execute a significant turnaround,” Einhorn wrote.
The position in BSX makes Greenlight among the largest shareholders in the company, joining other investor heavyweights such as Dodge & Cox, PrimeCap Managment and BlackRock Inc.
Einhorn is one of the more colorful and successful investors on Wall Street. His funds have produced 22 percent annualized returns since its inception in 1996, according to Greenlight.
A 2008 New York Magazine profile of Einhorn describes him as, “something of a legend on Wall Street, not only for his investing prowess, but also because of an unusual achievement: An accomplished bridge player who has played against (former CEO) Jimmy Cayne of Bear Stearns fame, he took up poker on a lark—and won $660,000 at the 2006 World Series of Poker. But Einhorn is entirely lacking in Vegas bravado. He’s mild-mannered to a fault. Which give his utterances all the more power.”
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
His card skills aside, Einhorn is perhaps most famous for publicly announcing his firm was shorting Lehamn Brothers in May 2008 during a speech at the Ira W. Sohn Investment Research Conference. He attacked the now defunct investment bank for its recklessness and putting the financial system at risk, closing the speech by saying that regulators should “guide Lehman toward a recapitalization and recognition of its losses—hopefully before federal taxpayer assistance is required,” according to the magazine.
The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
